Want to see VASO full AI Analyst Report?
VASO Stock Chart & Stats
$0.17
>-$0.01(-2.42%)
At close: 4:00 PM EST
$0.17
>-$0.01(-2.42%)
Day’s Range― - ―
52-Week Range$0.11 - $0.25
Previous CloseN/A
Volume57.70K
Average Volume (3M)98.46K
Market Cap
$33.87M
Enterprise Value$10.32
Total Cash (Recent Filing)$21.97M
Total Debt (Recent Filing)$2.40M
Price to Earnings (P/E)18.7
Beta0.54
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding175,998,030
10 Day Avg. Volume66,687
30 Day Avg. Volume98,461
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)1.04
Price to Sales (P/S)0.35
P/FCF Ratio3.68
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetA very low debt-to-equity ratio and sizeable equity provide durable financial resilience. This reduces refinancing risk and gives management flexibility to weather short-term revenue/margin swings, preserving strategic optionality over the next several months.
High Gross MarginsSustained ~60%+ gross margins indicate structural pricing power or low variable cost of delivery in the business model. That margin buffer supports profitability recovery if revenue stabilizes, and helps protect cash flow as the company addresses operating cost issues.
Demonstrated Prior Cash GenerationHistorical episodes of strong operating and free cash flow show the business can generate cash under the right conditions. This suggests current cash weakness may be cyclical or execution-related rather than structural, implying potential for medium-term recovery if trends reverse.
Bears Say
Revenue ContractionA near-12% TTM revenue decline signals weakening demand or loss of traction, which is a durable headwind for growth. Over a 2–6 month horizon this reduces operating leverage and makes margin recovery harder without clear signs of renewed top-line momentum.
Negative Operating & Free Cash FlowSustained negative operating and free cash flow erodes liquidity and reduces financial flexibility to invest or absorb shocks. Even with low leverage, persistent cash deficits can force cost cuts, asset sales, or external financing that constrain strategic options.
Deteriorated Operating ProfitabilityThe shift from strong margins to near-breakeven demonstrates weakening core profitability and higher execution risk. Without sustained margin improvement, any revenue recovery will translate less to net earnings, limiting reinvestment capacity and shareholder return potential.
Vaso News
VASO FAQ
What was Vaso Corp.’s price range in the past 12 months?
Vaso Corp. lowest stock price was $0.10 and its highest was $0.25 in the past 12 months.
What is Vaso Corp.’s market cap?
Vaso Corp.’s market cap is $33.87M.
When is Vaso Corp.’s upcoming earnings report date?
Vaso Corp.’s upcoming earnings report date is Aug 17, 2026 which is in 26 days.
How were Vaso Corp.’s earnings last quarter?
Currently, no data Available
Is Vaso Corp. overvalued?
According to Wall Street analysts Vaso Corp.’s price is currently Overvalued.
Does Vaso Corp. pay dividends?
Vaso Corp. does not currently pay dividends.
What is Vaso Corp.’s EPS estimate?
Vaso Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vaso Corp. have?
Vaso Corp. has 175,998,030 shares outstanding.
What happened to Vaso Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vaso Corp.?
Currently, no hedge funds are holding shares in VASO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vaso Corp.
Vaso Corporation is a diversified enterprise engaged in both the healthcare equipment and information technology industries, serving markets within the United States and globally. The company's operations are structured across three primary divisions: 1. IT (Information Technology): This segment is dedicated to providing specialized IT solutions for the healthcare sector, alongside managed network technology services. Its services encompass managed diagnostic imaging applications, network infrastructure management, network transport, and comprehensive cybersecurity solutions. 2. Professional Sales Service: This division primarily focuses on the distribution of capital medical equipment manufactured by General Electric Healthcare (GEHC) to mid-sized healthcare providers. Its offerings include GEHC diagnostic imaging hardware, associated service contracts, training programs, and financial services facilitated by both GEHC and external partners. 3. Equipment: This segment concentrates on the development, manufacturing, sales, and servicing of its own proprietary medical devices. Its product portfolio features the Biox series, which includes Holter monitors and ambulatory blood pressure recorders; the ARCS series software for analyzing, reporting, and communicating ECG and blood pressure data; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation (EECP) therapy systems, used for non-invasive, outpatient treatment of ischemic heart disease. Founded in 1987, the company was originally named Vasomedical, Inc. before officially rebranding as Vaso Corporation in November 2016. Vaso Corporation maintains its corporate headquarters in Plainview, New York.
Technical Analysis
Healthcare Triangle
―
HeartBeam
―
VSee Health
―
BullFrog AI Holdings, Inc.
―
Mangoceuticals, Inc.
―